{"entity":{"type":"insider","cik":"0001271389","url":"/insider/0001271389","json_url":"/insider/0001271389.json","name":"DOUGLASS DAVID L","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":9,"n_filings":5,"first":"2009-03-03","last":"2016-03-23","span_basis":"filed_date"},"name_variants":[{"name":"DOUGLASS DAVID L","source":"filing","n_filings":5,"first_seen":"2009-03-03","last_seen":"2016-03-23"}],"transactions":[{"id":3208873,"accession":"0001209191-16-110187","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-110187","line_url":"/filing/0001209191-16-110187","is_derivative":false,"issuer_cik":"0001255743","issuer_name":"Senseonics Holdings, Inc.","issuer_ticker":"SENS","issuer_name_source":null,"issuer_url":"/issuer/0001255743","owner_cik":null,"owner_name":"PAKIANATHAN DEEPIKA; DOUGLASS DAVID L; Delphi Management Partners VIII, L.L.C.; BOCHNOWSKI JAMES J; Delphi BioInvestments VIII LP; ROEDER DOUGLAS A; DELPHI VENTURES VIII LP","owner_display_name":"PAKIANATHAN DEEPIKA","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1228070.0,"shares_display":"1,228,070","price_per_share":2.85,"price_display":"2.85","price_state":"stated","total_value":3499999.5,"total_display":"3,499,999.50","total_whole":"3,500,000","shares_owned_after":11237221.0,"shares_owned_after_display":"11,237,221","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-03-23","filed_date":"2016-03-23","scope":"insider","n_lines":2},{"id":6205582,"accession":"0001209191-14-062753","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-14-062753","line_url":"/filing/0001209191-14-062753","is_derivative":false,"issuer_cik":"0001255743","issuer_name":"Calithera Biosciences, Inc.","issuer_ticker":"CALA","issuer_name_source":null,"issuer_url":"/issuer/0001255743","owner_cik":null,"owner_name":"Delphi Management Partners VIII, L.L.C.; DELPHI VENTURES VIII LP; PAKIANATHAN DEEPIKA; ROEDER DOUGLAS A; BOCHNOWSKI JAMES J; Delphi BioInvestments VIII LP; DOUGLASS DAVID L","owner_display_name":"Delphi Management Partners VIII, L.L.C.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500000.0,"shares_display":"500,000","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":5000000.0,"total_display":"5,000,000.00","total_whole":"5,000,000","shares_owned_after":2403238.0,"shares_owned_after_display":"2,403,238","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-10-07","filed_date":"2014-10-09","scope":"insider","n_lines":2},{"id":6875113,"accession":"0001209191-14-034322","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-14-034322","line_url":"/filing/0001209191-14-034322","is_derivative":false,"issuer_cik":"0001255743","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001255743","owner_cik":null,"owner_name":"PAKIANATHAN DEEPIKA; Delphi Management Partners VII, L.L.C.; BOCHNOWSKI JAMES J; DOUGLASS DAVID L; DELPHI BIOINVESTMENTS VII LP; ROEDER DOUGLAS A; DELPHI VENTURES VII L P","owner_display_name":"PAKIANATHAN DEEPIKA","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":350000.0,"shares_display":"350,000","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":3500000.0,"total_display":"3,500,000.00","total_whole":"3,500,000","shares_owned_after":2835067.0,"shares_owned_after_display":"2,835,067","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-05-13","filed_date":"2014-05-15","scope":"insider","n_lines":2},{"id":6717430,"accession":"0000906344-14-000024","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000906344-14-000024","line_url":"/filing/0000906344-14-000024#line-6","is_derivative":false,"issuer_cik":"0001255743","issuer_name":"TriVascular Technologies, Inc.","issuer_ticker":"TRIV","issuer_name_source":null,"issuer_url":"/issuer/0001255743","owner_cik":null,"owner_name":"DOUGLASS DAVID L; Delphi Management Partners VIII, L.L.C.; PAKIANATHAN DEEPIKA; ROEDER DOUGLAS A; DELPHI BIOINVESTMENTS VII LP; Delphi BioInvestments VIII LP; Delphi Management Partners VII, L.L.C.; DELPHI VENTURES VIII LP; BOCHNOWSKI JAMES J; DELPHI VENTURES VII L P","owner_display_name":"DOUGLASS DAVID L","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":833333.0,"shares_display":"833,333","price_per_share":12.0,"price_display":"12.00","price_state":"stated","total_value":9999996.0,"total_display":"9,999,996.00","total_whole":"9,999,996","shares_owned_after":833333.0,"shares_owned_after_display":"833,333","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-04-22","filed_date":"2014-04-24","scope":"insider"},{"id":5717724,"accession":"0001181431-09-013220","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-09-013220","line_url":"/filing/0001181431-09-013220","is_derivative":false,"issuer_cik":"0001230355","issuer_name":"TRANS1 INC","issuer_ticker":"TSON","issuer_name_source":null,"issuer_url":"/issuer/0001230355","owner_cik":null,"owner_name":"DELPHI VENTURES VI LP; ROEDER DOUGLAS A; PAKIANATHAN DEEPIKA; DOUGLASS DAVID L; MARONEY JOHN F; DELPHI MANAGEMENT PARTNERS VI LLC; BOCHNOWSKI JAMES J; DELPHI BIOINVESTMENTS VI LP","owner_display_name":"DELPHI VENTURES VI LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":5.9,"price_display":"5.90","price_state":"stated","total_value":295000.0,"total_display":"295,000.00","total_whole":"295,000","shares_owned_after":49517.0,"shares_owned_after_display":"49,517","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-02-27","filed_date":"2009-03-03","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001616543","name":"Senseonics Holdings, Inc.","url":"/issuer/0001616543","role":"Ten percent owner","n_filings":1,"first_seen":"2016-03-23","last_seen":"2016-03-23"},{"type":"issuer","type_label":"ISSUER","cik":"0001496671","name":"Calithera Biosciences, Inc.","url":"/issuer/0001496671","role":"Ten percent owner","n_filings":1,"first_seen":"2014-10-09","last_seen":"2014-10-09"},{"type":"issuer","type_label":"ISSUER","cik":"0001423824","name":"ALDER BIOPHARMACEUTICALS INC","url":"/issuer/0001423824","role":"Ten percent owner","n_filings":1,"first_seen":"2014-05-15","last_seen":"2014-05-15"},{"type":"issuer","type_label":"ISSUER","cik":"0001432732","name":"TriVascular Technologies, Inc.","url":"/issuer/0001432732","role":"Ten percent owner","n_filings":1,"first_seen":"2014-04-24","last_seen":"2014-04-24"},{"type":"issuer","type_label":"ISSUER","cik":"0001230355","name":"TRANS1 INC","url":"/issuer/0001230355","role":"Ten percent owner","n_filings":1,"first_seen":"2009-03-03","last_seen":"2009-03-03"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001271389","retrieved_at":"2026-08-24T04:09:12+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}